跳至主要内容
临床试验/NCT02840786
NCT02840786已完成不适用

Occlusive Disease of Lower Extremity

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 221 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
221
试验地点
1
主要终点
12-month Primary Patency Rate

研究概览

简要总结

This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

详细描述

This is a randomized study comparing balloon angioplasty adjunctive stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients were included if they were de novo stenosis>70% or occlusion of the femoropopliteal at least 18 years of age and referred for claudication (Rutherford-Becker class II-III) or critical limb ischemia (Rutherford-Becker class IV-V). They were excluded if they had one or more of the following:
  • •Acute or subacute lower limb ischemia;
  • •Severe calcification lesions;
  • •Total occlusions lesions more significant than 10 cm or total occlusion lesions with a suspicion of subintimal wire recanalization
  • •untreated ipsilateral iliac artery stenosis>70%, or the distal runoff artery <1 root;
  • •Previously lower extremity intervention or surgical graft artery bypass;
  • •Severe renal insufficiency, creatinine level greater than 2.5 mg/dL;
  • •The patient's platelet count is less than 100,000/uL, antiplatelet or anticoagulant contraindications to required medications;
  • •Patients with immune system diseases or malignant tumours;
  • •ongoing active infection
  • •decompensated congestive heart failure or acute coronary syndrome;
  • •Unwillingness to return for future follow-up visits

排除标准

  • 未提供

研究组 & 干预措施

Intervention: Stents

Active Comparator

Stents group

干预措施: balloon and Stent (Device)

Intervention: Atherectomy

Active Comparator

directional atherectomy group

干预措施: plaque excision system (Device)

结局指标

主要结局

12-month Primary Patency Rate

时间窗: 12 months

systolic velocity ratio \>2.4 as measured by Duplex ultrasound.

次要结局

  • Technical success(1 day)
  • freedom from clinically-driven TLR(12 months)
  • Major Adverse Events at 12-month Post Procedure(12 months)
  • 12-month Limb Salvage Rate(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Study of Stent Versus Direct Atherectomy to... | 临床试验